文献速递慢性肾脏病肾血管病与高血压

高磷与甲状旁腺激素在实验性慢性肾脏病中对骨丢失和血管钙化的独立调控

High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

本研究在肾切除高磷饮食大鼠中通过甲状旁腺切除联合PTH 1-34补充正常化血清PTH,区分高磷与PTH对血管钙化和骨丢失的独立作用。结果显示正常化PTH使主动脉钙降低80%、减轻骨丢失,并发现高PTH通过PTH1R信号增强高磷诱导的血管平滑肌细胞钙化。

要点

  • 正常化PTH可减少高磷尿毒症大鼠主动脉钙80%并减轻骨丢失
  • 高PTH通过PTH1R信号增强高磷诱导的血管平滑肌细胞钙化
  • 高磷尿毒症中PTH抑制缺陷加剧血管钙化和骨丢失

核心结论

  • 在高磷血症性CKD中,对高PTH的抑制缺陷会加剧高磷介导的血管平滑肌细胞成骨分化和降低血管抗钙化sclerostin水平。

研究设计与样本

  • 肾切除大鼠喂高磷饮食,行假手术或甲状旁腺切除联合PTH 1-34补充以正常化血清PTH。
  • 体外将血管平滑肌细胞暴露于高磷和高钙环境,观察PTH对钙沉积的影响。

主要发现

  • 甲状旁腺切除联合PTH 1-34补充使主动脉钙降低80%,伴α-actin升高、Runx2和BMP2降低及sclerostin升高,尽管高磷血症、肾损伤和血清Klotho程度相似。
  • 该干预主要通过减弱骨吸收和Wnt抑制剂升高来预防骨丢失。
  • 血清骨化三醇降低70%,尽管血清Fgf23、钙和肾脏24-羟化酶显著降低,对Fgf23是肾脏骨化三醇产生主要调节者的观点提出疑问。
  • 血管平滑肌细胞仅暴露于高磷和高钙时,高PTH通过PTH1R信号增强钙沉积,低PTH减弱钙沉积。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In chronic kidney disease (CKD), increases in serum phosphate and parathyroid hormone (PTH) aggravate vascular calcification (VC) and bone loss. This study was designed to discriminate high phosphorus (HP) and PTH contribution to VC and bone loss. METHODS: Nephrectomized rats fed a HP diet underwent either sham operation or parathyroidectomy and PTH 1-34 supplementation to normalize serum PTH. RESULTS: In uraemic rats fed a HP diet, parathyroidectomy with serum PTH 1-34 supplementation resulted in (i) reduced aortic calcium (80%) by attenuating osteogenic differentiation (higher α-actin; reduced Runx2 and BMP2) and increasing the Wnt inhibitor Sclerostin, despite a similar degree of hyperphosphataemia, renal damage and serum Klotho; (ii) prevention of bone loss mostly by attenuating bone resorption and increases in Wnt inhibitors; and (iii) a 70% decrease in serum calcitriol levels despite significantly reduced serum Fgf23, calcium and renal 24-hydroxylase, which questions that Fgf23 is the main regulator of renal calcitriol production. Significantly, when vascular smooth muscle cells (VSMCs) were exposed exclusively to high phosphate and calcium, high PTH enhanced while low PTH attenuated calcium deposition through parathyroid hormone 1 receptor (PTH1R) signalling. CONCLUSIONS: In hyperphosphataemic CKD, a defective suppression of high PTH exacerbates HP-mediated osteogenic VSMC differentiation and reduces vascular levels of anti-calcifying sclerostin.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Carrillo-López N, Panizo S, Alonso-Montes C, et al. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease. Nephrol Dial Transplant. 2019. PMID: 30189026. doi:10.1093/ndt/gfy287

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。